Currently the CEO for Pace Wealth Management. Last headed a Venture Fund - VC Hunt and prior to that as Head Global Finance for Ranbaxy Laboratories, a $1.4 Billion and the 9th largest Generic Pharma company worldwide. Instrumental in developing Ranbaxy businesses across geographies as CFO for its operations in China, Russia and the African continent. Advising private funds in Life Sciences and Health Care investments. FCA, B Com (Hons), M&A (Wharton, USA).